Health
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question – The Lancet
Since the onset of the COVID-19 pandemic, SARS-CoV-2 vaccine development has progressedat an unprecedented rate, with recent phase 3 trial data offering the tantalising…
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.
Copyright © 2021 Elsevier Inc. except certain content provided by third parties.
Privacy Policy Terms and Conditions
Continue Reading
-
General24 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
General14 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Noosa News23 hours agoCouncil steps up staff protection after surge in abuse
-
Business16 hours agoOrd Minnett names 2 ASX 200 shares to buy